2026-04-28T21:35:21Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/181642024-11-28T15:27:03Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927col_20.500.12105_16960
Repisalud
author
Sobrino-García, Miriam
author
Moreno, Esther M.
author
Muñoz-Bellido, Francisco J.
author
Gracia-Bara, Maria T.
author
Laffond, Elena
author
Doña, Inmaculada
author
Martín, Cristina
author
Macías, Eva M.
author
de Arriba, Sonia
author
Campanón, Valle
author
Gallardo, Alicia
author
Dávila, Ignacio
authoraffiliation
[Sobrino-García,M; Moreno,EM; Muñoz-Bellido,FJ; Gracia-Bara,MT; Laffond,E; Martín,C; Macías,EM; de Arriba,S; Campanón,V; Gallardo,A; Dávila,I] Allergy Service, University Hospital of Salamanca, Salamanca, Spain. [Moreno,EM; Muñoz-Bellido,FJ; Gracia-Bara,MT; Laffond,E; Martín,C; Macías,EM; de Arriba,S; Dávila,I] Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. [Moreno,EM; Muñoz-Bellido,FJ; Laffond,E; Macías,EM; de Arriba,S; Dávila,I] Department of Biomedical and Diagnostic Sciences, Faculty of Medicine, University of Salamanca, Salamanca, Spain. [Moreno,EM; Doña,I; Dávila,I] Asthma, Allergic and Adverse Reactions (ARADyAL), Network for Cooperative Research in Health of Instituto de Salud Carlos III, Salamanca University Hospital, Salamanca, Spain. [Doña,I] Allergy Service, University Hospital of Malaga, Malaga, Spain. [Doña,I] Biomedical Research Institute of Malaga (IBIMA), Malaga, Spain.
2024-02-12T19:48:10Z
2024-02-12T19:48:10Z
2020-11-30
http://hdl.handle.net/10668/3838
http://hdl.handle.net/20.500.12105/18164
33746738
10.3389/fphar.2020.584633
1663-9812
Frontiers in Pharmacology
Introduction: Being labelled as allergic to different drugs results in patients receiving other treatments, which are more toxic, less effective and more expensive. We aimed to analyze different studies of the costs of drug hypersensitivity assessment. Methods: A bibliographic search on studies regarding this issue was performed, including the available scientific evidence up to June 2020. We searched three databases with terms related to costs and allergy testing in drug hypersensitivity reactions. Results: Our search revealed 1,430 publications, of which 20 met the inclusion criteria. In the manuscript, prospective studies evaluating the costs of the evaluation of patients with suspected allergy to beta-lactams or non-steroidal anti-inflammatory drugs are analyzed. Also, comment is made on the costs associated with incorrect labeling as non-steroidal anti-inflammatory drug or penicillin hypersensitivity. Conclusions: Taking all costs into account, the study of drug hypersensitivity is not expensive, particularly considering the economic and clinical consequences of labeling a patient with hypersensitivity to drugs.
eng
Beta-lactam
Cost
Delabelling
Drug hypersensitivity
Non-steroidal anti-inflammatory drug
Penicillin
Drug allergy
Beta-lactamas
Costos y análisis de costo
Hipersensibilidad a las drogas
Antiinflamatorios no esteroideos
Penicilinas
Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents
review article